| Heidi Anne Haskell, OT | |
|
10315 Professional Cir, Reno, NV 89521-5861 | |
| (775) 982-5860 | |
| Not Available |
| Full Name | Heidi Anne Haskell |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Physical Rehabilitation |
| Location | 10315 Professional Cir, Reno, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558131243 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0019X | Occupational Therapist - Physical Rehabilitation | 0045 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Heidi Anne Haskell, OT 10315 Professional Cir, Reno, NV 89521-5861 Ph: (775) 982-5860 | Heidi Anne Haskell, OT 10315 Professional Cir, Reno, NV 89521-5861 Ph: (775) 982-5860 |
News Archive
NicOx S.A. today announced that a Marketing Authorization Application (MAA) for naproxcinod has been submitted to the European Medicines Agency (EMEA) through the centralized procedure, seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA).
Using mice, lab-grown cells and clues from a related disorder, Johns Hopkins researchers have greatly increased understanding of the causes of systemic sclerosis, showing that a critical culprit is a defect in the way certain cells communicate with their structural scaffolding
To celebrate 40 years of pioneering bioethics publication, the Hastings Center Report, the world's first bioethics journal, looked to the future, asking young scholars to write about what the next generation of bioethicists should take up. Out of 195 compelling submissions, four of the best essays were selected for publication in the November-December issue.
Baxter International Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] as a treatment for multifocal motor neuropathy (MMN). This is the first immunoglobulin treatment approved for MMN patients in the United States, and it was approved for use with MMN patients in Europe in 2011.
As people age, their immune systems age, too. And new research at Washington University School of Medicine in St. Louis suggests that aging immune cells increase the risk for age-related macular degeneration, a major cause of blindness in the United States.
› Verified 9 days ago
Amanda Greager, OTD Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3685 Lakeside Dr, Reno, NV 89509 Phone: 775-984-4204 Fax: 775-490-3001 | |
Janet R Mcknight, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3700 Grant Dr Ste A, Reno, NV 89509 Phone: 775-829-4700 Fax: 775-829-4710 | |
Jennifer Godfrey, OTR/L, DRS Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 975 Kirman Ave, Reno, NV 89502 Phone: 775-785-7263 | |
Marcy Kelto, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1881 Three Mile Dr, Reno, NV 89509 Phone: 906-250-3933 | |
Lauren Elizabeth Farrar-olsen, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10315 Professional Cir, Reno, NV 89521 Phone: 775-315-5010 | |
Annelise Boge, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9520 Prototype Ct, Reno, NV 89521 Phone: 775-852-6323 Fax: 775-852-6321 | |
Margaret Ann Batzloff, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2045 Silverada Blvd, Reno, NV 89512 Phone: 775-359-3161 Fax: 775-331-2878 |